| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Diamedica Therapeutics Inc. (DMAC) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. DMAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.83M | $51.63M | - | |
| 10% | 8.38M | $49.04M | - | |
| 10% | 4.96M | $29.01M | - | |
| Other | 450.0K | $2.63M | - | |
| Dir | 398.6K | $2.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2019 | Alcorn Harry W Jr | Chief Medical Officer | Buy | 150 | $4.46 | $668.39 | +15.0% | |
| Dec 11, 2018 | Xiao Zhenyu | Director, 10% Owner | Buy | 3,250 | $4.00 | $13,000.00 | +84.4% | |
| Dec 11, 2018 | Verdoorn Todd A. | Chief Scientific Officer | Buy | 1,000 | $4.00 | $4,000.00 | +100.0% | |
| Dec 11, 2018 | Pauls Dietrich John49 | President And CEO | Buy | 5,000 | $4.00 | $20,000.00 | +20.2% | |
| Dec 11, 2018 | Kellen Scott | CFO And Secretary | Buy | 1,250 | $4.00 | $5,000.00 | +61.3% | |
| Dec 11, 2018 | Alcorn Harry W Jr | Chief Medical Officer | Buy | 1,000 | $4.00 | $4,000.00 | New | |
| Dec 11, 2018 | Pilnik Richard D.47 | Director | Buy | 6,250 | $4.00 | $25,000.00 | +35.5% | |
| Dec 11, 2018 | Parsons James T. | Director | Buy | 2,250 | $4.00 | $9,000.00 | +58.4% | |
| Dec 11, 2018 | Giuffre Randall Michael84 | Director | Buy | 11,250 | $4.00 | $45,000.00 | +15.1% |